CONMED Corp — Director's Dealing 2021

Feb 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2021-02-04

Reporting Person: Pelletier Johonna Marie (Treasurer and VP, Tax)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-04	Common Stock	M	3000	$41.93	Acquired	6881	Direct
2021-02-04	Common Stock	S	3000	$116.0869	Disposed	3881	Direct
2021-02-04	Common Stock	M	2000	$59.96	Acquired	5881	Direct
2021-02-04	Common Stock	S	2000	$116.111	Disposed	3881	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-04	Options To Purchase Common Stock	$41.93	M	3000	Disposed	2027-03-01	Common Stock (3000)	Direct
2021-02-04	Options To Purchase Common Stock	$59.96	M	2000	Disposed	2028-03-01	Common Stock (2000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.00 to $116.44. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.00 to $116.37. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F3: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.